Hello,
Do we know any details about the biotech team in NYC at Canaccord? What is their deal flow and culture like? Do they focus on M&A or mostly ECM? What is the pay and career progression at the senior analyst level?
Thank you in advance!
| +67 | PWP acquisition by Piper cancelled | 27 | 1d |
| +59 | Is my MD a grifter? 16 years, 8 firms | 17 | 6h |
| +43 | No return offer - UPDATE. | 12 | 1d |
| +40 | Article: UBS Wall Street Rebuild Is a Study in Management Failure | 7 | 2d |
| +40 | "Corporate & Investment Banking" Analyst - Why? | 34 | 5h |
| +29 | Lack of talent in IB! | 25 | 10h |
| +28 | What Are The Best Boutiques 2026/2027 | 16 | 11h |
| +24 | Wells Fargo Calling Themselves a BB? | 16 | 13h |
| +24 | Moat of modelling in PE/Finance completely vanished; | 3 | 1d |
| +23 | Internal lateral from coverage to M&A (focused on coverage) | 8 | 1h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Bump
bump
Aspernatur ipsa sed perferendis impedit quidem. Voluptatem vel quo exercitationem commodi. Mollitia cum rerum accusamus qui itaque.
Adipisci perspiciatis molestiae illo veniam. Ut reprehenderit vero impedit consequatur excepturi.
Ducimus nulla rerum eius ipsum repellat consequatur autem. Velit reiciendis facilis nulla architecto sed harum esse consequatur. Earum itaque ut voluptatem impedit iusto labore. Architecto id voluptatem amet.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...